Brief: Neuroscientific Biopharmaceuticals Says Resignation Of CEO Stephen Carter
01/12/2023 01:28
Dec 1 (Reuters) - NeuroScientific Biopharmaceuticals Ltd
NSB.AX :
* RESIGNATION OF CEO STEPHEN CARTER
Source text for Eikon: ID:nASX22P8gH
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO